TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

Abstract Metaplastic breast cancers (MBCs) are characterized by complex genomes, which seem to vary according to their histologic subtype. TERT promoter hotspot mutations and gene amplification are rare in common forms of breast cancer, but present in a subset of phyllodes tumors. Here, we sought to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Edaise M. da Silva, Pier Selenica, Mahsa Vahdatinia, Fresia Pareja, Arnaud Da Cruz Paula, Lorenzo Ferrando, Andrea M. Gazzo, Higinio Dopeso, Dara S. Ross, Ariya Bakhteri, Nadeem Riaz, Sarat Chandarlapaty, Pedram Razavi, Larry Norton, Hannah Y. Wen, Edi Brogi, Britta Weigelt, Hong Zhang, Jorge S. Reis-Filho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/f132c81e88b1476593e2db603427ca32
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f132c81e88b1476593e2db603427ca32
record_format dspace
spelling oai:doaj.org-article:f132c81e88b1476593e2db603427ca322021-12-02T14:30:23ZTERT promoter hotspot mutations and gene amplification in metaplastic breast cancer10.1038/s41523-021-00250-82374-4677https://doaj.org/article/f132c81e88b1476593e2db603427ca322021-04-01T00:00:00Zhttps://doi.org/10.1038/s41523-021-00250-8https://doaj.org/toc/2374-4677Abstract Metaplastic breast cancers (MBCs) are characterized by complex genomes, which seem to vary according to their histologic subtype. TERT promoter hotspot mutations and gene amplification are rare in common forms of breast cancer, but present in a subset of phyllodes tumors. Here, we sought to determine the frequency of genetic alterations affecting TERT in a cohort of 60 MBCs with distinct predominant metaplastic components (squamous, 23%; spindle, 27%; osseous, 8%; chondroid, 42%), and to compare the repertoire of genetic alterations of MBCs according to the presence of TERT promoter hotspot mutations or gene amplification. Forty-four MBCs were subjected to: whole-exome sequencing (WES; n = 27) or targeted sequencing of 341-468 cancer-related genes (n = 17); 16 MBCs were subjected to Sanger sequencing of the TERT promoter, TP53 and selected exons of PIK3CA, HRAS, and BRAF. TERT promoter hotspot mutations (n = 9) and TERT gene amplification (n = 1) were found in 10 of the 60 MBCs analyzed, respectively. These TERT alterations were less frequently found in MBCs with predominant chondroid differentiation than in other MBC subtypes (p = 0.01, Fisher’s exact test) and were mutually exclusive with TP53 mutations (p < 0.001, CoMEt). In addition, a comparative analysis of the MBCs subjected to WES or targeted cancer gene sequencing (n = 44) revealed that MBCs harboring TERT promoter hotspot mutations or gene amplification (n = 6) more frequently harbored PIK3CA than TERT wild-type MBCs (n = 38; p = 0.001; Fisher’s exact test). In conclusion, TERT somatic genetic alterations are found in a subset of TP53 wild-type MBCs with squamous/spindle differentiation, highlighting the genetic diversity of these cancers.Edaise M. da SilvaPier SelenicaMahsa VahdatiniaFresia ParejaArnaud Da Cruz PaulaLorenzo FerrandoAndrea M. GazzoHiginio DopesoDara S. RossAriya BakhteriNadeem RiazSarat ChandarlapatyPedram RazaviLarry NortonHannah Y. WenEdi BrogiBritta WeigeltHong ZhangJorge S. Reis-FilhoNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Edaise M. da Silva
Pier Selenica
Mahsa Vahdatinia
Fresia Pareja
Arnaud Da Cruz Paula
Lorenzo Ferrando
Andrea M. Gazzo
Higinio Dopeso
Dara S. Ross
Ariya Bakhteri
Nadeem Riaz
Sarat Chandarlapaty
Pedram Razavi
Larry Norton
Hannah Y. Wen
Edi Brogi
Britta Weigelt
Hong Zhang
Jorge S. Reis-Filho
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
description Abstract Metaplastic breast cancers (MBCs) are characterized by complex genomes, which seem to vary according to their histologic subtype. TERT promoter hotspot mutations and gene amplification are rare in common forms of breast cancer, but present in a subset of phyllodes tumors. Here, we sought to determine the frequency of genetic alterations affecting TERT in a cohort of 60 MBCs with distinct predominant metaplastic components (squamous, 23%; spindle, 27%; osseous, 8%; chondroid, 42%), and to compare the repertoire of genetic alterations of MBCs according to the presence of TERT promoter hotspot mutations or gene amplification. Forty-four MBCs were subjected to: whole-exome sequencing (WES; n = 27) or targeted sequencing of 341-468 cancer-related genes (n = 17); 16 MBCs were subjected to Sanger sequencing of the TERT promoter, TP53 and selected exons of PIK3CA, HRAS, and BRAF. TERT promoter hotspot mutations (n = 9) and TERT gene amplification (n = 1) were found in 10 of the 60 MBCs analyzed, respectively. These TERT alterations were less frequently found in MBCs with predominant chondroid differentiation than in other MBC subtypes (p = 0.01, Fisher’s exact test) and were mutually exclusive with TP53 mutations (p < 0.001, CoMEt). In addition, a comparative analysis of the MBCs subjected to WES or targeted cancer gene sequencing (n = 44) revealed that MBCs harboring TERT promoter hotspot mutations or gene amplification (n = 6) more frequently harbored PIK3CA than TERT wild-type MBCs (n = 38; p = 0.001; Fisher’s exact test). In conclusion, TERT somatic genetic alterations are found in a subset of TP53 wild-type MBCs with squamous/spindle differentiation, highlighting the genetic diversity of these cancers.
format article
author Edaise M. da Silva
Pier Selenica
Mahsa Vahdatinia
Fresia Pareja
Arnaud Da Cruz Paula
Lorenzo Ferrando
Andrea M. Gazzo
Higinio Dopeso
Dara S. Ross
Ariya Bakhteri
Nadeem Riaz
Sarat Chandarlapaty
Pedram Razavi
Larry Norton
Hannah Y. Wen
Edi Brogi
Britta Weigelt
Hong Zhang
Jorge S. Reis-Filho
author_facet Edaise M. da Silva
Pier Selenica
Mahsa Vahdatinia
Fresia Pareja
Arnaud Da Cruz Paula
Lorenzo Ferrando
Andrea M. Gazzo
Higinio Dopeso
Dara S. Ross
Ariya Bakhteri
Nadeem Riaz
Sarat Chandarlapaty
Pedram Razavi
Larry Norton
Hannah Y. Wen
Edi Brogi
Britta Weigelt
Hong Zhang
Jorge S. Reis-Filho
author_sort Edaise M. da Silva
title TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
title_short TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
title_full TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
title_fullStr TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
title_full_unstemmed TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
title_sort tert promoter hotspot mutations and gene amplification in metaplastic breast cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f132c81e88b1476593e2db603427ca32
work_keys_str_mv AT edaisemdasilva tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT pierselenica tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT mahsavahdatinia tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT fresiapareja tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT arnauddacruzpaula tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT lorenzoferrando tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT andreamgazzo tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT higiniodopeso tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT darasross tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT ariyabakhteri tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT nadeemriaz tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT saratchandarlapaty tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT pedramrazavi tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT larrynorton tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT hannahywen tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT edibrogi tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT brittaweigelt tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT hongzhang tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
AT jorgesreisfilho tertpromoterhotspotmutationsandgeneamplificationinmetaplasticbreastcancer
_version_ 1718391226825179136